172 related articles for article (PubMed ID: 19049980)
1. SKI and MEL1 cooperate to inhibit transforming growth factor-beta signal in gastric cancer cells.
Takahata M; Inoue Y; Tsuda H; Imoto I; Koinuma D; Hayashi M; Ichikura T; Yamori T; Nagasaki K; Yoshida M; Matsuoka M; Morishita K; Yuki K; Hanyu A; Miyazawa K; Inazawa J; Miyazono K; Imamura T
J Biol Chem; 2009 Jan; 284(5):3334-3344. PubMed ID: 19049980
[TBL] [Abstract][Full Text] [Related]
2. c-Ski overexpression promotes tumor growth and angiogenesis through inhibition of transforming growth factor-beta signaling in diffuse-type gastric carcinoma.
Kiyono K; Suzuki HI; Morishita Y; Komuro A; Iwata C; Yashiro M; Hirakawa K; Kano MR; Miyazono K
Cancer Sci; 2009 Oct; 100(10):1809-16. PubMed ID: 19594546
[TBL] [Abstract][Full Text] [Related]
3. Differential role of Sloan-Kettering Institute (Ski) protein in Nodal and transforming growth factor-beta (TGF-β)-induced Smad signaling in prostate cancer cells.
Vo BT; Cody B; Cao Y; Khan SA
Carcinogenesis; 2012 Nov; 33(11):2054-64. PubMed ID: 22843506
[TBL] [Abstract][Full Text] [Related]
4. Ski acts as a co-repressor with Smad2 and Smad3 to regulate the response to type beta transforming growth factor.
Xu W; Angelis K; Danielpour D; Haddad MM; Bischof O; Campisi J; Stavnezer E; Medrano EE
Proc Natl Acad Sci U S A; 2000 May; 97(11):5924-9. PubMed ID: 10811875
[TBL] [Abstract][Full Text] [Related]
5. The oncoprotein Ski acts as an antagonist of transforming growth factor-beta signaling by suppressing Smad2 phosphorylation.
Prunier C; Pessah M; Ferrand N; Seo SR; Howe P; Atfi A
J Biol Chem; 2003 Jul; 278(28):26249-57. PubMed ID: 12732634
[TBL] [Abstract][Full Text] [Related]
6. Arkadia represses the expression of myoblast differentiation markers through degradation of Ski and the Ski-bound Smad complex in C2C12 myoblasts.
Yuzawa H; Koinuma D; Maeda S; Yamamoto K; Miyazawa K; Imamura T
Bone; 2009 Jan; 44(1):53-60. PubMed ID: 18950738
[TBL] [Abstract][Full Text] [Related]
7. SKI knockdown inhibits human melanoma tumor growth in vivo.
Chen D; Lin Q; Box N; Roop D; Ishii S; Matsuzaki K; Fan T; Hornyak TJ; Reed JA; Stavnezer E; Timchenko NA; Medrano EE
Pigment Cell Melanoma Res; 2009 Dec; 22(6):761-72. PubMed ID: 19845874
[TBL] [Abstract][Full Text] [Related]
8. The oncoprotein c-ski functions as a direct antagonist of the transforming growth factor-{beta} type I receptor.
Ferrand N; Atfi A; Prunier C
Cancer Res; 2010 Nov; 70(21):8457-66. PubMed ID: 20959473
[TBL] [Abstract][Full Text] [Related]
9. Chromatin immunoprecipitation on microarray analysis of Smad2/3 binding sites reveals roles of ETS1 and TFAP2A in transforming growth factor beta signaling.
Koinuma D; Tsutsumi S; Kamimura N; Taniguchi H; Miyazawa K; Sunamura M; Imamura T; Miyazono K; Aburatani H
Mol Cell Biol; 2009 Jan; 29(1):172-86. PubMed ID: 18955504
[TBL] [Abstract][Full Text] [Related]
10. The murine gastrin promoter is synergistically activated by transforming growth factor-beta/Smad and Wnt signaling pathways.
Lei S; Dubeykovskiy A; Chakladar A; Wojtukiewicz L; Wang TC
J Biol Chem; 2004 Oct; 279(41):42492-502. PubMed ID: 15292219
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of Smad transcriptional corepressors SnoN and Ski in the fibrotic kidney: an amplification mechanism for TGF-beta1 signaling.
Yang J; Zhang X; Li Y; Liu Y
J Am Soc Nephrol; 2003 Dec; 14(12):3167-77. PubMed ID: 14638915
[TBL] [Abstract][Full Text] [Related]
12. Ski inhibits TGF-β/phospho-Smad3 signaling and accelerates hypertrophic differentiation in chondrocytes.
Kim KO; Sampson ER; Maynard RD; O'Keefe RJ; Chen D; Drissi H; Rosier RN; Hilton MJ; Zuscik MJ
J Cell Biochem; 2012 Jun; 113(6):2156-66. PubMed ID: 22461172
[TBL] [Abstract][Full Text] [Related]
13. Efficient TGF-β/SMAD signaling in human melanoma cells associated with high c-SKI/SnoN expression.
Javelaud D; van Kempen L; Alexaki VI; Le Scolan E; Luo K; Mauviel A
Mol Cancer; 2011 Jan; 10(1):2. PubMed ID: 21211030
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-beta suppresses the ability of Ski to inhibit tumor metastasis by inducing its degradation.
Le Scolan E; Zhu Q; Wang L; Bandyopadhyay A; Javelaud D; Mauviel A; Sun L; Luo K
Cancer Res; 2008 May; 68(9):3277-85. PubMed ID: 18451154
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor beta regulates parathyroid hormone-related protein expression in MDA-MB-231 breast cancer cells through a novel Smad/Ets synergism.
Lindemann RK; Ballschmieter P; Nordheim A; Dittmer J
J Biol Chem; 2001 Dec; 276(49):46661-70. PubMed ID: 11590145
[TBL] [Abstract][Full Text] [Related]
16. c-Ski accelerates renal cancer progression by attenuating transforming growth factor β signaling.
Taguchi L; Miyakuni K; Morishita Y; Morikawa T; Fukayama M; Miyazono K; Ehata S
Cancer Sci; 2019 Jun; 110(6):2063-2074. PubMed ID: 30972853
[TBL] [Abstract][Full Text] [Related]
17. c-Ski acts as a transcriptional co-repressor in transforming growth factor-beta signaling through interaction with smads.
Akiyoshi S; Inoue H; Hanai J; Kusanagi K; Nemoto N; Miyazono K; Kawabata M
J Biol Chem; 1999 Dec; 274(49):35269-77. PubMed ID: 10575014
[TBL] [Abstract][Full Text] [Related]
18. Two short segments of Smad3 are important for specific interaction of Smad3 with c-Ski and SnoN.
Mizuide M; Hara T; Furuya T; Takeda M; Kusanagi K; Inada Y; Mori M; Imamura T; Miyazawa K; Miyazono K
J Biol Chem; 2003 Jan; 278(1):531-6. PubMed ID: 12426322
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of c-Ski as a co-repressor in transforming growth factor-beta signaling correlates with progression of esophageal squamous cell carcinoma.
Fukuchi M; Nakajima M; Fukai Y; Miyazaki T; Masuda N; Sohda M; Manda R; Tsukada K; Kato H; Kuwano H
Int J Cancer; 2004 Mar; 108(6):818-24. PubMed ID: 14712482
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor-I inhibits transcriptional responses of transforming growth factor-beta by phosphatidylinositol 3-kinase/Akt-dependent suppression of the activation of Smad3 but not Smad2.
Song K; Cornelius SC; Reiss M; Danielpour D
J Biol Chem; 2003 Oct; 278(40):38342-51. PubMed ID: 12876289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]